09:31 AM EDT, 05/13/2024 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) said Monday that it has signed an accelerated share repurchase agreement with investment bank Jefferies to buy back $35 million of its common stock.

Collegium said it will execute the deal as part of a $150 million share repurchase program the board authorized in January.

Following the completion of the agreement, Collegium will have $115 million remaining under the program.

Price: 31.40, Change: -0.10, Percent Change: -0.32